These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 5872246)
1. [Examination of the blood lipoprotein and glucoprotein content in myxedema treated with triiodothyronine]. Kliachko VR; Saitgaleeva MSh Probl Endokrinol Gormonoter; 1965; 11(5):8-14. PubMed ID: 5872246 [No Abstract] [Full Text] [Related]
2. [Blood glycoproteins in patients with myxedema during prolonged replacement hormone therapy]. Kliachko VR; Samokhvalova MA Probl Endokrinol (Mosk); 1968; 14(1):33-7. PubMed ID: 5736993 [No Abstract] [Full Text] [Related]
3. [The content of somatotropin in the blood of myxedema patients treated with triiodthyronine]. Kliachko VR; Balabolkin MI Probl Endokrinol Gormonoter; 1966; 12(1):49-53. PubMed ID: 6008550 [No Abstract] [Full Text] [Related]
4. [Sodium and potassium content in the blood serum and erythrocytes in myxedema treated with triiodothyronine]. Kliachko VR; Saltykhanov RM Probl Endokrinol (Mosk); 1967; 13(2):31-4. PubMed ID: 5620062 [No Abstract] [Full Text] [Related]
5. [Cardiocirculatory and electrocardiographic modifications in myxedema of the adult treated with L-triiodothyronine]. Benedetti A; Cattano G G Clin Med; 1965 Jul; 46(7):521-48. PubMed ID: 5864753 [No Abstract] [Full Text] [Related]
6. Quantitative immunoelectrophoresis of human serum proteins. Clarke HG; Freeman T Clin Sci; 1968 Oct; 35(2):403-13. PubMed ID: 5721242 [No Abstract] [Full Text] [Related]
7. Decreased sensitivity to warfarin in patients with myxedema. Rice AJ; McIntosh TJ; Fouts JR; Brunk SF; Wilson WR Am J Med Sci; 1971 Oct; 262(4):211-5. PubMed ID: 5142577 [No Abstract] [Full Text] [Related]
8. [Concerning the efficacy of substitution hormone therapy with triiodthyronine in myxedema; clinico-electroencephalographic parallels]. Kliachko VR; Frenkel' GM; Dobrzhanskaia AK Probl Endokrinol Gormonoter; 1965; 11(6):25-31. PubMed ID: 5874643 [No Abstract] [Full Text] [Related]
9. [Scleromyxedema Arndt-Gottron: a paraproteinemic disease]. Piper W; Hardmeier T; Schäfer E Schweiz Med Wochenschr; 1967 Jul; 97(26):829-38. PubMed ID: 5613452 [No Abstract] [Full Text] [Related]
10. [Beta-endorphins in the blood of patients with thyrotoxicosis and myxedema]. Felt V; Nedvídková J Cas Lek Cesk; 1984 Oct; 123(42):1270-2. PubMed ID: 6095997 [No Abstract] [Full Text] [Related]
11. [Various indices of collagen and mucopolysaccharide metabolism in patients with primary myxedema treated with triiodothyronine]. Kristi GS; Kliachko VR; Kanaeva TN Probl Endokrinol (Mosk); 1968; 14(1):44-8. PubMed ID: 4242823 [No Abstract] [Full Text] [Related]
12. [Myxedema coma. A successfully treated case]. Bergdahl B; Karlberg B Nord Med; 1970 Aug; 84(34):1077-9. PubMed ID: 5455391 [No Abstract] [Full Text] [Related]
13. [Congenital hypothyroidism & myxedema, treated with triiodothyronine, with special reference to the ECG]. LANGANKE E Munch Med Wochenschr; 1957 Mar; 99(13):454-5. PubMed ID: 13430688 [No Abstract] [Full Text] [Related]